Sarepta Therapeutics · 1 day ago
Senior Manager, Scientific Communications
Sarepta Therapeutics is at the forefront of genetic medicine, focusing on Duchenne muscular dystrophy and other diseases. The Senior Manager, Scientific Communications, will lead publication activities and ensure high-quality scientific publications while collaborating with internal teams and external authors.
BiotechnologyGeneticsHealth CareTherapeutics
Responsibilities
Support the development and revision of a strategic Sci Comms plan for the assigned therapeutic platform(s) as they relate to GHRA tactics including publication and congress plans
Serve as the lead on publications (abstracts, posters, presentations, and manuscripts) and work with authors, evidence generation teams, and medical communication agencies to ensure the timely execution of publication plans, ensuring a high quality and timely product, as well as adherence to publication SOPs and associated procedures
Review draft publications for scientific quality and data accuracy, and ensure alignment with author direction
Present and review the assigned publication plan and conference data disclosures at internal cross-functional team meetings, as needed
Interface with external experts (e.g., physicians, other health care professionals, health economists) and effectively collaborate with cross-functional teams
Explore opportunities for publication enhancements (plain language summaries/plain language summary publications/infographics) for the assigned product to increase the value of publications in scientific exchange
Communicate the publication development process and industry guidance on good publication practices and authorship criteria to team members as needed
Manage publication agency partners and contractors in the execution of publication and scientific communications tactics
Contribute to budget management, forecasting, and resource allocation for the assigned therapeutic platform(s); actively track publication expenditures and ensure that they are within the approved budget
Contribute to relevant medical communication activities, which may include but are not limited to slide decks, internal medical training, and company-sponsored symposia content development
Serve as the Sci Comms representative at relevant internal team meetings
Attend scientific conferences and provide coverage support as assigned
Qualification
Required
An advanced Scientific Degree (Ph.D., PharmD) required. A Master's Degree will be considered with significant publication planning and writing experience
At least 5 years of medical/scientific publication planning and development experience in the pharmaceutical/biotech industry or at medical communication agencies
Ability to understand and interpret scientific data
Excellent organizational, interpersonal, and communication (verbal, written, presentation) skills with flawless attention to detail
Experience in the rare disease/neurology therapeutic area
Familiarity with publications management databases such as iEnvision
Experience developing HEOR, real-world evidence, or patient-reported outcomes publications
Good understanding of industry guidelines related to scientific publications
Working knowledge of statistical concepts
Proficient in Microsoft Windows, Word, Excel, and PowerPoint
Experience working with fast-paced, collaborative, cross-functional teams
Ability to prioritize and support business-critical or emergent critical publications in response to evolving business needs
Preferred
Relevant professional certification/credential (e.g., CMPP, AMWA) is preferred
Benefits
Physical and Emotional Wellness
Financial Wellness
Support for Caregivers
Company
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$2.88BKey Investors
Michael Andrew ChambersPharmakon AdvisorsMidCap Financial
2025-12-11Post Ipo Debt· $291.4M
2025-08-21Post Ipo Equity
2025-08-21Post Ipo Debt· $602M
Leadership Team
Recent News
BioWorld Financial Watch
2026-01-09
2025-12-22
Company data provided by crunchbase